drugset / Trial / NCT02357836
Neoadjuvant Itraconazole in Non-small Cell Lung Cancer
Phase 0
Completed
13 enrolled
University of Texas Southwestern Medical Center
United States Department of Defense · collab
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to determine the pharmacodynamics effects of itraconazole in early-stage non-small cell lung cancer.
Timeline
- Start
- 2015-06
- Primary completion
- 2018-07
- Completion
- 2018-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Itraconazole | Small molecule | 600 mg | Oral |